Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Oct 30;18(5):1161–1169.e5. doi: 10.1016/j.cgh.2019.10.036

Table 2.

SNP stratified tumor marker levels in discovery set controls

CA19-9 number Mean (U/mL) SD Mean +/− 3 SD*
FUT3 (−/−) 26 2.7 2.3 9.5
FUT3 (+/−) 85 7.4 5.4 23.5
FUT3 (+/+) 75 10.9 9.1 38.1
FUT2 (−/−) 59 22.8 14.6 66.6
Uniform diagnostic cut-off (Not SNP-stratified) 245 11.7 11.5 46.1
CEA number Mean (ng/mL) SD Mean +/− 3 SD*
FUT2+/blood B 26 1.2 1.8 6.6
FUT2+/non-blood B 151 0.7 0.7 2.8
FUT2 −/− /blood B 4 1.5 0.9 4.3
FUT2 −/− /non blood B 55 1.3 0.9 4.0
smoker 9 1.7 0.8 4.2
Uniform diagnostic cut-off (Not SNP-stratified) 245 0.9 1.0 3.9
CA125 number Mean (U/mL) SD Mean +/− 3 SD*
GAL3ST2 rs12469459-AA 101 7.4 5.0 22.3
GAL3ST2 rs12469459-TT 90 5.2 3.7 16.2
GAL3ST2 rs12469459-TT 26 4.3 2.1 10.7
Uniform diagnostic cut-off (Not SNP-stratified) 217 6.1 4.4 19.2